Nevertheless, SGLT2-i can improve the control of blood glucose without causing the above side effects because that the factors of hypertension, glomerular hyperfiltration and weight gain are controlled by SGLT2 gene (6). This evidence concerns the gene SLC5A2 and hypertensive disorder.